Neuropace, Inc. NPCE Number of Vested and Expected to Vest Options
Number of Vested and Expected to Vest Options at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber.
The official record: Neuropace, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neuropace, Inc.'s number of vested and expected to vest options.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neuropace, Inc.'s number of vested and expected to vest options?
- Neuropace, Inc. (NPCE) reported number of vested and expected to vest options of 2.6M in Q1 2026.
- How has Neuropace, Inc.'s number of vested and expected to vest options changed year-over-year?
- Neuropace, Inc.'s number of vested and expected to vest options increased by 0.1% year-over-year, from 2.6M to 2.6M.
- What is the long-term trend for Neuropace, Inc.'s number of vested and expected to vest options?
- Over 4 years (2021 to 2025), Neuropace, Inc.'s number of vested and expected to vest options has grown at a -3.8% compound annual growth rate (CAGR), from 3M to 2.6M.
- What does number of vested and expected to vest options mean?
- This metric represents the total number of share-based payment options that have either met their vesting requirements or are reasonably expected to vest based on current service conditions. It serves as a key indicator of potential future dilution for existing shareholders. Investors use this figure to assess the magnitude of equity-based compensation commitments and the potential impact on future earnings per share.